These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 151629)

  • 21. Backward walking and circling: behavioural responses induced by drug treatments which cause simultaneous release of catecholamines and 5-hydroxytryptamine.
    Curzon G; Fernando JC; Lees AJ
    Br J Pharmacol; 1979 Aug; 66(4):573-9. PubMed ID: 465894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fenfluramine-induced enhancement of confinement motor activity: an indirect 5-hydroxytryptamine-like action?
    Clineschmidt BV; McGuffin JC; Pflueger AB; Totaro JA
    Neuropharmacology; 1975 Apr; 14(4):301-11. PubMed ID: 124023
    [No Abstract]   [Full Text] [Related]  

  • 23. Serotonergic involvement in neuroendocrine function.
    Schettini G; Quattrone A; Di Renzo G; Preziosi P
    Pharmacol Res Commun; 1980 Mar; 12(3):249-54. PubMed ID: 6446722
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of d-fenfluramine, MK-212, and ondansetron on saline drinking in two-choice tests in the rehydrating rat.
    Cooper SJ; Barber DJ
    Pharmacol Biochem Behav; 1993 Jul; 45(3):593-6. PubMed ID: 8332621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central tryptaminergic mediation of the hyperthermia induced by amphetamine and halogenated analogues of it?
    Frey HH
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):89-90. PubMed ID: 128750
    [No Abstract]   [Full Text] [Related]  

  • 26. Accumulation of hypothalamic endorphins after repeated injections of anorectics which release serotonin.
    Harsing LG; Yang HY; Costa E
    J Pharmacol Exp Ther; 1982 Dec; 223(3):689-94. PubMed ID: 6292396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral effects of fenfluramine mediated via the release of 5-hydroxytryptamine.
    Mottram DR; Patel RJ
    Gen Pharmacol; 1979; 10(6):441-4. PubMed ID: 520795
    [No Abstract]   [Full Text] [Related]  

  • 28. Differential analgetic actions of amphetamine enantiomers in the mouse: a drug-drug interaction study.
    Tocco DR; Spratto GR; Maickel RP
    Arch Int Pharmacodyn Ther; 1985 Dec; 278(2):261-72. PubMed ID: 2937379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. d-Fenfluramine and salbutamol: two drugs causing anorexia through different neurochemical mechanisms.
    Garattini S; Samanin R
    Int J Obes; 1984; 8 Suppl 1():151-7. PubMed ID: 6534892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in vivo effects of d-fenfluramine: no apparent relation between 5-hydroxytryptamine release and hypophagia.
    Raiteri M; Bonanno G; Vallebuona F
    J Pharmacol Exp Ther; 1995 May; 273(2):643-9. PubMed ID: 7752066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fenfluramine and 5-hydroxytryptamine. Part 2: Involvement of brain 5-hydroxytryptamine in the anorectic activity of fenfluramine.
    Duhault J; Boulanger M; Voisin C; Malen C; Schmitt H
    Arzneimittelforschung; 1975 Nov; 25(11):1758-62. PubMed ID: 128366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different action of 5-hydroxytryptamine (5-HT) uptake inhibitors on fenfluramine- but not p-chloramphetamine-induced hyperthermia in rats.
    Paełowski L
    J Pharm Pharmacol; 1981 Aug; 33(8):538-40. PubMed ID: 6115932
    [No Abstract]   [Full Text] [Related]  

  • 33. Behavioral evidence for the rapid release of CNS serotonin by PCA and fenfluramine.
    Trulson ME; Jacobs BL
    Eur J Pharmacol; 1976 Mar; 36(1):149-54. PubMed ID: 131036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drugs that enhance central serotoninergic transmission diminish elective carbohydrate consumption by rats.
    Wurtman JJ; Wurtman RJ
    Life Sci; 1979 Mar; 24(10):895-903. PubMed ID: 221766
    [No Abstract]   [Full Text] [Related]  

  • 35. Hydroxytryptamine uptake inhibitors block para- methoxyamphetamine-induced 5-HT release.
    Tseng LF
    Br J Pharmacol; 1979 Jun; 66(2):185-90. PubMed ID: 313827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological evidence for the central serotonergic effects of monomethoxyamphetamines.
    Menon MK; Tseng LF; Loh HH
    J Pharmacol Exp Ther; 1976 May; 197(2):272-9. PubMed ID: 946817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The increased release of 3H-5-hydroxytryptamine by d-para-methoxyamphetamine and d-amphetamine in vivo.
    Tseng LF
    Proc West Pharmacol Soc; 1976; 19():136-41. PubMed ID: 1036622
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of quipazine and D-fenfluramine, two serotonin-like drugs, on TSH secretion in basal and cold stimulated conditions in the rat.
    Di Renzo GF; Quattrone A; Schettini G; Preziosi P
    Life Sci; 1978 Jun; 22(21):1879-85. PubMed ID: 672433
    [No Abstract]   [Full Text] [Related]  

  • 39. Sleep suppressant action of fenfluramine in rats. I. Relation to postsynaptic serotonergic stimulation.
    Fornal C; Radulovacki M
    J Pharmacol Exp Ther; 1983 Jun; 225(3):667-74. PubMed ID: 6683311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MK-212: a serotonin-like agonist in the CNS.
    Clineschidmt BV
    Gen Pharmacol; 1979; 10(4):287-90. PubMed ID: 488663
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.